Comparision Of Efficay And Adverse Effects Of Two Topicals In Treatment Of Localised Alopecia Areata - METHOTREXATE ONE PERCENTAGE GEL TOFACITINIB Versus TWO PERCENTAGE GE
Not Applicable
- Conditions
- Health Condition 1: L638- Other alopecia areata
- Registration Number
- CTRI/2024/06/069460
- Lead Sponsor
- DR M Yashaswini
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Patients of more than 18 Years.
2.Patients of both the genders.
3.Patients of localised alopecia over any part of the body.
Exclusion Criteria
1.Patients with other systemic illness-Cardiac, Renal, Hepatic Illness.
2.Severely immunocompromised.
3.Pregnancy.
4.Patients who have undergone treatment recently with other modalities in Past 6 weeks.
5.PATIENT NOT GIVING CONSENT FOR THE STUDY
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Trichoscopic Evaluation . <br/ ><br>Lesional Area Density (LAD) SCORE. <br/ ><br>Global Photographic Assessment (GPA) ScaleTimepoint: Baseline . <br/ ><br>Two weeks. <br/ ><br>Four weeks. <br/ ><br>Six weeks. <br/ ><br>Eight weeks . <br/ ><br>Ten weeks. <br/ ><br>Twelve weeks . <br/ ><br>Fourteen weeks. <br/ ><br>Sixteen weeks. <br/ ><br>
- Secondary Outcome Measures
Name Time Method Post treatment adverse effects & efficacy of TOFACITINIB 2% GEL & METHOTREXATE 1 % GELTimepoint: Follow up visit for every 2 weeks i.e, 2,4,6,8 till 8 weeks